Point-of-care testing-new horizons for cross-sectional technologies and decentralized application strategies.
Anal Bioanal Chem
2022
414
10
3161-3163
SARS-CoV-2 viral load dynamics in immunocompromised critically ill patients on remdesivir treatment.
Multidiscip Respir Med
2022
17
High Quality Performance of Novel Immunoassays for the Sensitive Quantification of Soluble PD-1, PD-L1 and PD-L2 in Blood.
Biomedicines
2022
10
10
Cytotoxic FCER1G+ innate-like T cells: new potential for tumour immunotherapy.
Signal Transduct Target Ther
2022
7
1
Robust Preanalytical Performance of Soluble PD-1, PD-L1 and PD-L2 Assessed by Sensitive ELISAs in Blood.
Biomedicines
2022
10
10
Auto- Antibody Diagnostics in Diabetology - Current Status of Analytical Performance and Clinical Utility in Germany
Dibaetol Stoffwechs
2022
17
05
382-388
IKKα Promotes Intestinal Tumorigenesis by Limiting Recruitment of M1-like Polarized Myeloid Cells.
Cell Rep
2022
38
9
Detecting drug resistance in pancreatic cancer organoids guides optimized chemotherapy treatment.
J Pathol
2022
257
5
607-619
Failure Mode and Effects Analysis (FMEA) at the preanalytical phase for POCT blood gas analysis: proposal for a shared proactive risk analysis model.
Clin Chem Lab Med
2022
60
8
1186-1201
T Cells Directed against the Metastatic Driver Chondromodulin-1 in Ewing Sarcoma: Comparative Engineering with CRISPR/Cas9 vs. Retroviral Gene Transfer for Adoptive Transfer.
Cancers (Basel)
2022
14
22